Defunct Company
Total Trials
7
As Lead Sponsor
4
As Collaborator
3
Total Enrollment
4,609
NCT02273895
The Use of EEG in Alzheimer's Disease, With and Without Scopolamine - A Pilot Study
Phase: N/A
Role: Lead Sponsor
Start: Apr 30, 2004
Completion: Jan 31, 2010
NCT02273921
EEG Classification System for Dementia
Start: Mar 31, 2005
Completion: Jun 30, 2020
NCT02254213
Intra-individual Stability in Electroencephalography (EEG) Parameters
Start: Jun 30, 2005
Completion: Aug 31, 2007
NCT01922024
Detection of Microorganisms and Antibiotic Resistance Genes Using the Curetis Unyvero LRT55 Application
Start: Jun 30, 2015
Completion: Nov 30, 2016
NCT02623764
EEG-cholinergic Index and Clinical Response to Treatment With Cholinesterase Inhibitors
Role: Collaborator
Start: Dec 31, 2015
Completion: Nov 30, 2019
NCT02654691
Chronic Neuropathy Following Chemotherapy
Start: Jun 30, 2016
Completion: Jul 1, 2019
NCT03711331
Impact of a Strategy Based on Bacterial DNA Detection to Optimize Antibiotics in Patients With Hospital-acquired Pneumonia
Start: Jun 16, 2020
Completion: Jun 30, 2024